Insider Transactions Reported by 25 Insiders of Apellis Pharmaceuticals, Inc.

Symbol
APLS on Nasdaq
Location
Waltham, MA

Insiders trading volume in the past year

Apellis Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Morningside Venture Investments Ltd 10%+ Owner $815,635,922 18 Nov 2021
Cedric Francois Chief Executive Officer, Director $44,792,904 -$10,035,888 -18% 20 Jan 2026
Pascal Deschatelets Chief Scientific Officer $24,506,196 -$92,898 -0.38% 20 Jan 2026
Alec Machiels Director $19,212,760 01 Jan 2026
Timothy Eugene Sullivan Chief Financial Officer $9,211,255 -$1,629,345 -15% 20 Jan 2026
LUKAS SCHEIBLER Chief Research Officer $6,961,586 01 Dec 2023
Federico Grossi Chief Medical Officer $6,043,162 05 Jan 2023
David Watson General Counsel $5,017,600 -$1,662,087 -25% 20 Jan 2026
Kelley Boucher Chief People Officer $4,034,395 02 Sep 2025
A. Sinclair Dunlop Director $3,817,828 -$2,153,155 -36% 01 Jan 2026
Caroline Baumal Chief Medical Officer $3,367,655 -$114,347 -3.3% 20 Jan 2026
Mark Jeffrey DeLong Chief Business & Strat Officer $3,217,229 -$87,033 -2.6% 20 Jan 2026
Nur Nicholson Chief Technical Officer $3,160,206 -$126,047 -3.8% 20 Jan 2026
Victoria L. Brown Program Team Lead $3,142,798 20 Jan 2023
Adam J. Townsend Chief Commercial Officer $2,481,459 -$20,519 -0.82% 29 Jan 2025
Karen Lewis Chief People Officer $2,074,062 -$10,747 -0.52% 29 Jan 2025
LESLIE MELTZER Chief Research and Development $1,726,185 26 Aug 2025
Jeffrey Eisele Chief Development Officer $1,633,009 -$8,208 -0.5% 29 Jan 2025
James George Chopas VP/Chief Accounting Officer $1,244,774 -$58,240 -4.5% 20 Jan 2026
PAUL R. FONTEYNE Director $1,105,729 01 Jan 2026
CRAIG A. WHEELER Director $1,090,760 01 Jan 2026
Stephanie Monaghan O'Brien Director $987,579 01 Jan 2026
Gerald Chan Director $987,579 01 Jan 2026
Keli Walbert Director $910,719 01 Jan 2026
Nicole D. Perry Vice President - Accounting $717,179 02 Aug 2021

Recent Insider Transactions by Companies or Individuals for Apellis Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.